ASX - By Stock
|
IQ3 |
Re:
Ann: Addendum to 2021 Financial Report
|
|
anf0
|
6 |
3.6K |
0 |
07/04/22 |
07/04/22 |
ASX - By Stock
|
6
|
3.6K
|
0
|
|
NSX - By Stock
|
IQG |
Re:
Ann:iQG Seeks Voluntary Admin Today to Restructure (Price Sensitive)
|
|
anf0
|
8 |
14K |
1 |
07/04/22 |
07/04/22 |
NSX - By Stock
|
8
|
14K
|
1
|
|
ASX - By Stock
|
MNS |
Re:
Ann: Pause in Trading
|
|
anf0
|
79 |
44K |
2 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
79
|
44K
|
2
|
|
ASX - By Stock
|
MNS |
Re:
Ann: Pause in Trading
|
|
anf0
|
79 |
44K |
7 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
79
|
44K
|
7
|
|
ASX - By Stock
|
IQ3 |
Re:
Ann: Full Year Statutory Accounts
|
|
anf0
|
3 |
1.3K |
1 |
25/10/21 |
25/10/21 |
ASX - By Stock
|
3
|
1.3K
|
1
|
|
ASX - By Stock
|
MNS Energy |
Re:
Management
|
|
anf0
|
222 |
62K |
2 |
06/10/21 |
06/10/21 |
ASX - By Stock
|
222
|
62K
|
2
|
|
ASX - By Stock
|
MNS Energy |
Re:
Management
|
|
anf0
|
222 |
62K |
2 |
06/10/21 |
06/10/21 |
ASX - By Stock
|
222
|
62K
|
2
|
|
ASX - By Stock
|
MNS Energy |
Re:
Management
|
|
anf0
|
222 |
62K |
2 |
06/10/21 |
06/10/21 |
ASX - By Stock
|
222
|
62K
|
2
|
|
ASX - By Stock
|
MNS Energy |
Re:
Management
|
|
anf0
|
222 |
62K |
3 |
06/10/21 |
06/10/21 |
ASX - By Stock
|
222
|
62K
|
3
|
|
ASX - By Stock
|
MNS Energy |
Re:
Management
|
|
anf0
|
222 |
62K |
6 |
05/10/21 |
05/10/21 |
ASX - By Stock
|
222
|
62K
|
6
|
|
NSX - By Stock
|
IQG |
Re:
Ann:Annual Report 2021 (Price Sensitive)
|
|
anf0
|
4 |
4.3K |
0 |
24/09/21 |
24/09/21 |
NSX - By Stock
|
4
|
4.3K
|
0
|
|
NSX - By Stock
|
IQG |
Re:
Ann:Annual Report 2021 (Price Sensitive)
|
|
anf0
|
4 |
4.3K |
0 |
23/09/21 |
23/09/21 |
NSX - By Stock
|
4
|
4.3K
|
0
|
|
NSX - By Stock
|
IQG |
Re:
Ann:Portfolio Company Awarded $6.3M Federal Govt Grant (Price Sensitive)
|
|
anf0
|
2 |
2.8K |
2 |
10/07/21 |
10/07/21 |
NSX - By Stock
|
2
|
2.8K
|
2
|
|
ASX - By Stock
|
IQG |
Re:
GBS Inc
|
|
anf0
|
2 |
1.7K |
1 |
27/05/21 |
27/05/21 |
ASX - By Stock
|
2
|
1.7K
|
1
|
|
ASX - By Stock
|
APT |
Re:
The APT Downramping genius
|
|
anf0
|
199 |
53K |
1 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
199
|
53K
|
1
|
|
ASX - By Stock
|
APT |
Re:
The APT Downramping genius
|
|
anf0
|
199 |
53K |
2 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
199
|
53K
|
2
|
|
ASX - By Stock
|
APT |
Re:
The APT Downramping genius
|
|
anf0
|
199 |
53K |
6 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
199
|
53K
|
6
|
|
ASX - By Stock
|
MNS |
Re:
Ann: Executive Director Employment Ends
|
|
anf0
|
87 |
35K |
1 |
12/05/21 |
12/05/21 |
ASX - By Stock
|
87
|
35K
|
1
|
|
ASX - By Stock
|
MNS |
Re:
Ann: Executive Director Employment Ends
|
|
anf0
|
87 |
35K |
9 |
11/05/21 |
11/05/21 |
ASX - By Stock
|
87
|
35K
|
9
|
|
NSX - By Stock
|
IQG |
Re:
Ann:Progress of clinical programs
|
|
anf0
|
1 |
1.1K |
2 |
29/04/21 |
29/04/21 |
NSX - By Stock
|
1
|
1.1K
|
2
|
|
ASX - By Stock
|
IQ3 |
Re:
GBS Inc
|
|
anf0
|
5 |
3.7K |
1 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
5
|
3.7K
|
1
|
|
ASX - By Stock
|
MNS |
Re:
ALEVO BATTERY PLANT PURCHASE
|
|
anf0
|
35 |
13K |
2 |
01/02/21 |
01/02/21 |
ASX - By Stock
|
35
|
13K
|
2
|
|
ASX - By Stock
|
MNS |
Re:
How long before the big announcement?
|
|
anf0
|
495 |
248K |
1 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
495
|
248K
|
1
|
|
ASX - By Stock
|
MNS |
Re:
How long before the big announcement?
|
|
anf0
|
495 |
248K |
3 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
495
|
248K
|
3
|
|
ASX - By Stock
|
MNS |
Re:
How long before the big announcement?
|
|
anf0
|
495 |
248K |
3 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
495
|
248K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
anf0
|
1.0K |
515K |
4 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
1.0K
|
515K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
anf0
|
1.0K |
416K |
1 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
1.0K
|
416K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
anf0
|
1.0K |
416K |
1 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
1.0K
|
416K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
|
|
anf0
|
392 |
157K |
1 |
12/11/20 |
12/11/20 |
ASX - By Stock
|
392
|
157K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
|
|
anf0
|
392 |
157K |
0 |
12/11/20 |
12/11/20 |
ASX - By Stock
|
392
|
157K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Worst trade of the year
|
|
anf0
|
173 |
90K |
8 |
04/10/20 |
04/10/20 |
ASX - By Stock
|
173
|
90K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Worst trade of the year
|
|
anf0
|
173 |
90K |
12 |
04/10/20 |
04/10/20 |
ASX - By Stock
|
173
|
90K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Worst trade of the year
|
|
anf0
|
173 |
90K |
5 |
04/10/20 |
04/10/20 |
ASX - By Stock
|
173
|
90K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Worst trade of the year
|
|
anf0
|
173 |
90K |
12 |
04/10/20 |
04/10/20 |
ASX - By Stock
|
173
|
90K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
MSB to dispute FDA finding in Type A meeting
|
|
anf0
|
1.0K |
501K |
6 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
1.0K
|
501K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Company Update - Webcast and Forward Thoughts
|
|
anf0
|
273 |
127K |
9 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
273
|
127K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Company Update - Webcast and Forward Thoughts
|
|
anf0
|
273 |
127K |
2 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
273
|
127K
|
2
|
|
ASX - By Stock
|
PBH |
Re:
Ann: PointsBet Launches in Illinois
|
|
anf0
|
26 |
11K |
0 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
26
|
11K
|
0
|
|
ASX - By Stock
|
PBH |
Re:
Ann: Intention to Undertake a Capital Raise
|
|
anf0
|
216 |
98K |
0 |
31/08/20 |
31/08/20 |
ASX - By Stock
|
216
|
98K
|
0
|
|
ASX - By Stock
|
PBH |
Re:
Ann: Intention to Undertake a Capital Raise
|
|
anf0
|
216 |
98K |
0 |
30/08/20 |
30/08/20 |
ASX - By Stock
|
216
|
98K
|
0
|
|
ASX - By Stock
|
PBH |
Re:
Ann: Intention to Undertake a Capital Raise
|
|
anf0
|
216 |
98K |
0 |
30/08/20 |
30/08/20 |
ASX - By Stock
|
216
|
98K
|
0
|
|
ASX - By Stock
|
PBH |
Re:
Ann: Intention to Undertake a Capital Raise
|
|
anf0
|
216 |
98K |
2 |
29/08/20 |
29/08/20 |
ASX - By Stock
|
216
|
98K
|
2
|
|
ASX - By Stock
|
PBH |
Re:
Ann: Intention to Undertake a Capital Raise
|
|
anf0
|
216 |
98K |
4 |
28/08/20 |
28/08/20 |
ASX - By Stock
|
216
|
98K
|
4
|
|
ASX - By Stock
|
PBH |
Re:
Ann: Intention to Undertake a Capital Raise
|
|
anf0
|
216 |
98K |
2 |
28/08/20 |
28/08/20 |
ASX - By Stock
|
216
|
98K
|
2
|
|
ASX - By Stock
|
PBH |
Re:
Ann: Intention to Undertake a Capital Raise
|
|
anf0
|
216 |
98K |
6 |
28/08/20 |
28/08/20 |
ASX - By Stock
|
216
|
98K
|
6
|
|
ASX - By Stock
|
Medicine |
Re:
Remdesivir. - Game changer or not.
|
|
anf0
|
31 |
6.6K |
1 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
31
|
6.6K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
anf0
|
2.0K |
681K |
1 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
681K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
anf0
|
2.0K |
681K |
0 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
681K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
anf0
|
2.0K |
681K |
0 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
681K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
anf0
|
2.0K |
681K |
0 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
681K
|
0
|
|